Erratum: Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection (PLoS Pathogens (2014) 10:1 (e1003845) DOI: 10.1371/journal.ppat.1003845);Suppression of Interferon Lambda Signaling by SOCS-1 Results in Their Excessive Production during Influenza Virus Infection

PLoS Pathogens

Volumn 10, Issue 1, 2014, Pages

  Wei, Haitao ^a   Wang, Song ^a   Chen, Qinghuang ^b   Chen, Yuhai ^a   Chi, Xiaojuan ^b   Zhang, Lianfeng ^c   Huang, Shile ^d   Gao, George F ^a   Chen, Ji Long ^a,b  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 29; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR NFAT; INTERFERON; SOCS1 PROTEIN, MOUSE; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DENSITOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; IMMUNOFLUORESCENCE; INFLUENZA; INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG ALVEOLUS; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERFERONS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; ORTHOMYXOVIRIDAE INFECTIONS; PULMONARY ALVEOLI; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84893783668     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005402     Document Type: Erratum

References (59)

1. Teijaro JR, Walsh KB, Cahalan S, Fremgen DM, Roberts E, et al. (2011) Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146: 980-991.
2. Jewell NA, Cline T, Mertz SE, Smirnov SV, Flano E, et al. (2010) Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 84: 11515-11522.
3. Kumagai Y, Takeuchi O, Kato H, Kumar H, Matsui K, et al. (2007) Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity 27: 240-252.
4. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, et al. (2007) Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445: 319-323.
5. Iwasaki A, Medzhitov R, (2011) A new shield for a cytokine storm. Cell 146: 861-862.
6. Kelly C, Klenerman P, Barnes E, (2011) Interferon lambdas: the next cytokine storm. Gut 60: 1284-1293.
7. Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, et al. (2010) Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 84: 5670-5677.
8. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-68.
9. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77.
10. Iversen MB, Paludan SR, (2010) Mechanisms of type III interferon expression. J Interferon Cytokine Res 30: 573-578.
11. Okabayashi T, Kojima T, Masaki T, Yokota S, Imaizumi T, et al. (2011) Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res 160: 360-366.
12. Pott J, Mahlakoiv T, Mordstein M, Duerr CU, Michiels T, et al. (2011) IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A 108: 7944-7949.
13. Qiu X, Guo G, Chen K, Kashiwada M, Druker BJ, et al. (2012) A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis. Neoplasia 14: 547-558.
14. Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, et al. (1999) The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A 96: 2071-2076.
15. Ungureanu D, Saharinen P, Junttila I, Hilton DJ, Silvennoinen O, (2002) Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol 22: 3316-3326.
16. Waiboci LW, Ahmed CM, Mujtaba MG, Flowers LO, Martin JP, et al. (2007) Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist. J Immunol 178: 5058-5068.
17. Pauli EK, Schmolke M, Wolff T, Viemann D, Roth J, et al. (2008) Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 4: e1000196.
18. Pothlichet J, Chignard M, Si-Tahar M, (2008) Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J Immunol 180: 2034-2038.
19. Jia D, Rahbar R, Chan RW, Lee SM, Chan MC, et al. (2010) Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PLoS One 5: e13927.
20. Uetani K, Hiroi M, Meguro T, Ogawa H, Kamisako T, et al. (2008) Influenza A virus abrogates IFN-gamma response in respiratory epithelial cells by disruption of the Jak/Stat pathway. Eur J Immunol 38: 1559-1573.
21. Brand S, Zitzmann K, Dambacher J, Beigel F, Olszak T, et al. (2005) SOCS-1 inhibits expression of the antiviral proteins 2′,5′-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29. Biochem Biophys Res Commun 331: 543-548.
22. Wang S, Li H, Chen Y, Wei H, Gao GF, et al. (2012) Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins. J Biol Chem 287: 9804-9816.
23. Wang JP, Bowen GN, Padden C, Cerny A, Finberg RW, et al. (2008) Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 112: 2028-2034.
24. Bender A, Bui LK, Feldman MA, Larsson M, Bhardwaj N, (1995) Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J Exp Med 182: 1663-1671.
25. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997-1001.
26. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al. (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
27. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, et al. (2005) Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
28. Sommereyns C, Paul S, Staeheli P, Michiels T, (2008) IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4: e1000017.
29. Poat B, Hazari S, Chandra PK, Gunduz F, Balart LA, et al. (2010) SH2 modified STAT1 induces HLA-I expression and improves IFN-gamma signaling in IFN-alpha resistant HCV replicon cells. PLoS One 5: e13117.
30. Liddle FJ, Alvarez JV, Poli V, Frank DA, (2006) Tyrosine phosphorylation is required for functional activation of disulfide-containing constitutively active STAT mutants. Biochemistry 45: 5599-5605.
31. Onoguchi K, Yoneyama M, Takemura A, Akira S, Taniguchi T, et al. (2007) Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 282: 7576-7581.
32. Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, et al. (2004) Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431: 703-707.
33. Garcia CC, Russo RC, Guabiraba R, Fagundes CT, Polidoro RB, et al. (2010) Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. PLoS Pathog 6: e1001171.
34. Le Goffic R, Leymarie O, Chevalier C, Rebours E, Da Costa B, et al. (2011) Transcriptomic analysis of host immune and cell death responses associated with the influenza A virus PB1-F2 protein. PLoS Pathog 7: e1002202.
35. Lu D, Ma Y, Zhang W, Bao D, Dong W, et al. (2012) Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice. Hypertension 60: 81-89.
36. Yang J, Wang J, Chen K, Guo G, Xi R, et al. (2013) eIF4B phosphorylation by Pim kinases plays a critical role in cellular transformation by Abl oncogenes. Cancer Res 73: 4898-4908.
37. McKenna K, Beignon AS, Bhardwaj N, (2005) Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol 79: 17-27.
38. Takeuchi O, Akira S, (2009) Innate immunity to virus infection. Immunol Rev 227: 75-86.
39. La Gruta NL, Kedzierska K, Stambas J, Doherty PC, (2007) A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85: 85-92.
40. Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, et al. (2011) Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology 54: 1913-1923.
41. Li J, Hu S, Zhou L, Ye L, Wang X, et al. (2011) Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons. Glia 59: 58-67.
42. Svetlikova D, Kabat P, Ohradanova A, Pastorek J, Betakova T, (2010) Influenza A virus replication is inhibited in IFN-lambda2 and IFN-lambda3 transfected or stimulated cells. Antiviral Res 88: 329-333.
43. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, et al. (2009) Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol 182: 1296-1304.
44. Kimura A, Naka T, Nakahama T, Chinen I, Masuda K, et al. (2009) Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 206: 2027-2035.
45. Shen H, Lentsch AB, (2004) Progressive dysregulation of transcription factors NF-kappa B and STAT1 in prostate cancer cells causes proangiogenic production of CXC chemokines. Am J Physiol Cell Physiol 286: C840-847.
46. Wang Y, Wu TR, Cai S, Welte T, Chin YE, (2000) Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol Cell Biol 20: 4505-4512.
47. Austenaa LM, Carlsen H, Hollung K, Blomhoff HK, Blomhoff R, (2009) Retinoic acid dampens LPS-induced NF-kappaB activity: results from human monoblasts and in vivo imaging of NF-kappaB reporter mice. J Nutr Biochem 20: 726-734.
48. Kramer OH, Baus D, Knauer SK, Stein S, Jager E, et al. (2006) Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev 20: 473-485.
49. Strebovsky J, Walker P, Lang R, Dalpke AH, (2011) Suppressor of cytokine signaling 1 (SOCS1) limits NFkappaB signaling by decreasing p65 stability within the cell nucleus. FASEB J 25: 863-874.
50. Dai X, Sayama K, Yamasaki K, Tohyama M, Shirakata Y, et al. (2006) SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes. J Invest Dermatol 126: 1574-1581.
51. Fan K, Jia Y, Wang S, Li H, Wu D, et al. (2012) Role of Itk signalling in the interaction between influenza A virus and T-cells. J Gen Virol 93: 987-997.
52. Ahmed CM, Dabelic R, Waiboci LW, Jager LD, Heron LL, et al. (2009) SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system. J Virol 83: 1402-1415.
53. Guo G, Qiu X, Wang S, Chen Y, Rothman PB, et al. (2010) Oncogenic E17K mutation in the pleckstrin homology domain of AKT1 promotes v-Abl-mediated pre-B-cell transformation and survival of Pim-deficient cells. Oncogene 29: 3845-3853.
54. Zitzmann K, Brand S, De Toni EN, Baehs S, Goke B, et al. (2007) SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells. Cancer Res 67: 5025-5032.
55. Huang FJ, Steeg PS, Price JE, Chiu WT, Chou PC, et al. (2008) Molecular basis for the critical role of suppressor of cytokine signaling-1 in melanoma brain metastasis. Cancer Res 68: 9634-9642.
56. Shen L, Evel-Kabler K, Strube R, Chen SY, (2004) Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat Biotechnol 22: 1546-1553.
57. Jiang LJ, Zhang NN, Ding F, Li XY, Chen L, et al. (2011) RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation. Proc Natl Acad Sci U S A 108: 1897-1902.
58. Delaloye J, Roger T, Steiner-Tardivel QG, Le Roy D, Knaup Reymond M, et al. (2009) Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 5: e1000480.
59. Reed LJ, Muench H, (1938) A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology 27: 493-497.